139 related articles for article (PubMed ID: 23424776)
21. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.
Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B
J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies.
Wu L; Zhou H; Lin H; Qi J; Zhu C; Gao Z; Wang H
Reproduction; 2012 Mar; 143(3):389-97. PubMed ID: 22187671
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
[TBL] [Abstract][Full Text] [Related]
24. Comparison of inflammatory microRNA expression in healthy and periodontitis tissues.
Lee YH; Na HS; Jeong SY; Jeong SH; Park HR; Chung J
Biocell; 2011 Aug; 35(2):43-9. PubMed ID: 22128589
[TBL] [Abstract][Full Text] [Related]
25. Widespread deregulation of microRNA expression in human prostate cancer.
Ozen M; Creighton CJ; Ozdemir M; Ittmann M
Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
27. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
28. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M
Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219
[TBL] [Abstract][Full Text] [Related]
29. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA profiling of human gastric cancer.
Yao Y; Suo AL; Li ZF; Liu LY; Tian T; Ni L; Zhang WG; Nan KJ; Song TS; Huang C
Mol Med Rep; 2009; 2(6):963-70. PubMed ID: 21475928
[TBL] [Abstract][Full Text] [Related]
31. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
[TBL] [Abstract][Full Text] [Related]
32. Identification of recurrence-related genes by integrating microRNA and gene expression profiling of gastric cancer.
Yan Z; Xiong Y; Xu W; Li M; Cheng Y; Chen F; Ding S; Xu H; Zheng G
Int J Oncol; 2012 Dec; 41(6):2166-74. PubMed ID: 23007704
[TBL] [Abstract][Full Text] [Related]
33. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
34. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
[TBL] [Abstract][Full Text] [Related]
35. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
Roth P; Keller A; Hoheisel JD; Codo P; Bauer AS; Backes C; Leidinger P; Meese E; Thiel E; Korfel A; Weller M
Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293
[TBL] [Abstract][Full Text] [Related]
36. [Expression of microRNAs in lung homogenates in rats with chronic obstructive pulmonary disease].
Li B; Zhou X; Chen L; Feng C; Li T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):905-9. PubMed ID: 25476085
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
Shen X; Ye Y; Qi J; Shi W; Wu X; Ni H; Cong H; Ju S
Clin Chem Lab Med; 2017 May; 55(5):748-754. PubMed ID: 27155004
[TBL] [Abstract][Full Text] [Related]
38. The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A; Hofmeister CC; Pichiorri F
Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
[TBL] [Abstract][Full Text] [Related]
39. [The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].
Li X; Li D; Zhuang Y; Shi Q; Wei W; Zhang H; Ju XL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):138-43. PubMed ID: 23611221
[TBL] [Abstract][Full Text] [Related]
40. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures.
Seeliger C; Karpinski K; Haug AT; Vester H; Schmitt A; Bauer JS; van Griensven M
J Bone Miner Res; 2014 Aug; 29(8):1718-28. PubMed ID: 24431276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
